Cardiovascular Safety in Type 2 Diabetes With Sulfonylureas as Second-line Drugs: A Nationwide Population-Based Comparative Safety Study.
Wang H, Cordiner RLM, Huang Y, Donnelly L, Hapca S, Collier A, McKnight J, Kennon B, Gibb F, McKeigue P, Wild SH, Colhoun H, Chalmers J, Petrie J, Sattar N, MacDonald T, McCrimmon RJ, Morales DR, Pearson ER; Scottish Diabetes Research Network Epidemiology Group.
Wang H, et al.
Diabetes Care. 2023 May 1;46(5):967-977. doi: 10.2337/dc22-1238.
Diabetes Care. 2023.
PMID: 36944118
Free PMC article.
Clinical Trial.